BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/23/2014 3:34:00 PM | Browse: 1201 | Download: 980
Publication Name World Journal of Methodology
Manuscript ID 11514
Country Cyprus
Received
2014-05-26 18:08
Peer-Review Started
2014-05-26 22:57
To Make the First Decision
2014-07-18 12:38
Return for Revision
2014-07-18 15:10
Revised
2014-07-22 20:41
Second Decision
2014-10-16 15:14
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-10-16 15:57
Articles in Press
2014-10-16 15:57
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2014-12-11 18:42
Publish the Manuscript Online
2014-12-23 15:34
ISSN 2222-0682 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Pharmacology & Pharmacy
Manuscript Type Review
Article Title Transition of Thalassaemia and Friedreich ataxia from fatal to chronic diseases
Manuscript Source Invited Manuscript
All Author List Annita Kolnagou, Christina N Kontoghiorghe and George J Kontoghiorghes
Funding Agency and Grant Number
Corresponding Author George J Kontoghiorghes, PhD, Professor, Postgraduate Research Institute of Science, Technology, Environment and Medicine, 3 Ammochostou Street, Limassol 3021, Cyprus. kontoghiorghes.g.j@pri.ac.cy
Key Words Thalassaemia; Friedreich ataxia; Prenatal diagnosis; Survival; Chelation therapy; Deferiprone; Deferoxamine; Cyprus
Core Tip Thalassaemia major (TM) and Friedreich’s ataxia (FA) are inherited diseases related to iron toxicity, with high morbidity and mortality rates. Cyprus has the highest frequency of TM and FA worldwide. Prenatal diagnosis and other health policies almost abolished the birth of TM and FA patients in Cyprus. Deferiprone has increased the survival and quality of life of TM patients, who are now reaching normal life expectancy and it is also promising for FA patients. Personalised treatments are proposed for TM and FA. The Cyprus experience can be used as a paradigm for the prevention and treatment of TM worldwide.
Publish Date 2014-12-23 15:34
Citation Kolnagou A, Kontoghiorghe CN, Kontoghiorghes GJ. Transition of Thalassaemia and Friedreich ataxia from fatal to chronic diseases. World J Methodol 2014; 4(4): 197-218
URL http://www.wjgnet.com/2222-0682/full/v4/i4/197.htm
DOI http://dx.doi.org/10.5662/wjm.v4.i4.197
Full Article (PDF) WJM-4-197.pdf
Full Article (Word) WJM-4-197.doc
Manuscript File 11514-Review.doc
Answering Reviewers 11514-Answering reviewers.pdf
Copyright License Agreement 11514-Copyright assignment.pdf
Peer-review Report 11514-Peer review(s).pdf
Scientific Misconduct Check 11514-CrossCheck.jpg
Scientific Editor Work List 11514-Scientific editor work list.pdf